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Abstract 6 
ATTITUDES towards pain and its control in farm animals have lagged behind those 7 
in companion animal species. However, a considerable amount of work over the past 8 
15 years has focused on the perception of pain in cattle based on objective and 9 
subjective assessment by clinicians working with this species. A recent large-scale 10 
survey of cattle practitioners revealed that over half of the respondents felt their 11 
knowledge of pain and analgesia in cattle was inadequate or could be improved, and 12 
the majority of these identified a lack of readily available information on the subject 13 
as being a contributory factor. This article reviews current knowledge on pain 14 
assessment in cattle in a clinical setting, and discusses some protocols for pain 15 
management in specific conditions. 16 
Introduction 17 
Pain in humans has been described as “an unpleasant sensory and emotional 18 
experience with actual or potential tissue damage”. It is reasonable to suppose that 19 
animals experience pain in a similar way to humans because experimental work has 20 
demonstrated that the neural pathways of pain sensation are similar in human and 21 
other mammals. Application of the “precautionary principle” would also suggest that 22 
this is the safest assumption unless strong experimental evidence proves otherwise. 23 
Attitudes towards pain and its control in farm animals have lagged behind those in 24 
companion animal species. However, a considerable amount of work in recent years 25 
has focussed on perception of pain in cattle by clinicians working with the species, 26 
and on its subjective and objective assessment. 27 
 28 
In a recent large-scale survey of cattle practitioners (Huxley and Whay 2006), over 29 
half of respondents felt that their knowledge of pain and analgesia in cattle was 30 
inadequate or could be improved, and the majority of these identified a lack of readily 31 
available information on the subject as a contributory factor. This article reviews 32 
current knowledge on pain assessment in cattle in a clinical setting before discussing 33 
methods to prevent and alleviate it. 34 
 35 
The Physiology of Pain 36 
Pain results from by chemical, mechanical or thermal stimulation of free nerve 37 
endings containing nociceptors. Injury to cells in tissues causes release of 38 
inflammatory mediators (e.g. prostaglandins, histamine and bradykinin), which 39 
stimulate nociceptors in nearby nerve endings. This is an amplification process; a 40 
stimulus affecting a relatively small number of nerve endings stimulates many more. 41 
Impulses resulting from this stimulation are conducted via the ventrolateral part of the 42 
spinal cord to the brainstem and thalamus. There is further amplification at this level 43 
(centrally); this is known as “wind-up”. Conscious perception of pain is a result of 44 
activation of certain areas of the cerebral cortex (via the thalamus). Theoretically, pain 45 
is a central “experience” that occurs as a result of nociception in peripheral nerves. 46 
 47 
Tissue injury results in acute pain, which stimulates muscular action to avoid the 48 
noxious stimulus (either as a result of reflex limb flexion or via conscious 49 
mechanisms) and causes sympathetic autonomic nervous system activation and a 50 
heightened state of arousal. Increased sympathetic tone can become persistent if the 51 
insult is prolonged or severe. In chronic pain, the presence of high levels of 52 
inflammatory mediators around the site of injury and persistent activation of pain 53 
fibre pathways in the spinal cord leads to a decrease in pain threshold, so that stimuli 54 
are perceived as more painful than would be normal for the individual concerned. 55 
This is known as hyperalgesia. Another phenomenon associated with chronic pain is 56 
allodynia, whereby similar mechanisms lead to perception of normally non-painful 57 
stimuli as painful. Prevention or modulation of hyperalgesia and allodynia is one of 58 
the main objectives of analgesia. For example, a chronically lame cow may over time 59 
perceive the lesion as more painful than it was initially (hyperalgesia) and perceive 60 
pain in undamaged surrounding tissues on touch (allodynia). 61 
 62 
As well as implications for welfare, pain is also significant in terms of disease 63 
progression, potentially having a major effect on the physiological state of the animal 64 
(Otto and Short 1998). This may interfere with wound healing. 65 
 66 
Assessment and Recognition of Pain in Cattle 67 
A large volume of research has been conducted in the past 15 years in the field of pain 68 
assessment in ruminants. A number of methodologies have been employed 69 
experimentally to assess or quantify levels of pain experienced by animals. These can 70 
be broadly categorised as objective and subjective. Objective methods measure 71 
physiological stress responses (e.g. plasma cortisol levels), changes in levels of 72 
biochemical markers (e.g. acute phase proteins) or the incidence of clearly defined 73 
behaviour patterns (e.g. vocalisation). Subjective methods are value judgements made 74 
by the human observer. These will become more repeatable and reliable with 75 
appropriate experience and training. Subjective pain assessment relies on the 76 
evaluation of behaviour, posture and other cues. The degree of pain is then either 77 
described using a verbal descriptor (e.g. mild, moderate, severe), assigned a numerical 78 
value (e.g. zero to 10) or described using a visual analogue scale (e.g. placement of a 79 
mark somewhere on a line between no pain and the worst pain imaginable). 80 
 81 
In a practical situation, a variety of subjective indicators can be employed to assess 82 
pain, and this should form part of a standard clinical examination. The following 83 
indicators are useful in cattle: 84 
• Decrease in movement/locomotion 85 
• Decreased interaction with other animals in the group 86 
• Decreased feed intake (e.g. “hollow” left flank caused by an empty rumen) 87 
• Changes relevant to the source of the pain being experienced (e.g. altered 88 
locomotion, flank watching or kicking, ear twitching) 89 
• Level of mental activity/responsiveness (animals in severe pain often show reduced 90 
responsiveness to stimuli) 91 
• Changes in normal postures associated with pain (e.g. lateral recumbency, standing 92 
motionless, drooping of the ears) 93 
• Easily measurable indicators of physiological stress (e.g. increased heart rate, 94 
increased pupil size, altered rate and depth of respiration, trembling)  95 
• Bruxism (tooth grinding) 96 
• Poor coat condition (e.g. rough, dusty or unkempt) caused by decreased grooming  97 
As with all types of clinical examination, it is important to have a consistent approach 98 
to pain assessment, and ensure that the same behavioural and physiological signs are 99 
assessed in each animal. 100 
 101 
It is important to remember that cattle are stoical by nature because, as a species, they 102 
have been subject to a strong evolutionary pressure to mask pain and its implied 103 
weakness from predators. As a result they often do not demonstrate appreciable 104 
definite signs of pain until the stimulus is severe. Often, particularly in adult cattle, 105 
unwillingness to move may be the predominant indicator. This means that the 106 
precautionary principle should be applied, i.e. the clinician should err on the side of 107 
treating or preventing pain, as the cost of unnecessary treatment is relatively less 108 
severe than the cost of failing to manage animals that are suffering. 109 
 110 
Barriers to Treatment  111 
A survey by Huxley and Whay (2006) examined the reasons why practitioners tended 112 
to under-use analgesia in cattle. Over 90% of respondents to the survey considered 113 
that cattle benefited from analgesics as part of their treatment and that they recovered 114 
faster if they were administered; however, two thirds of respondents considered that 115 
the cost of analgesia was a major issue to their clients. Whilst the financial constraints 116 
of the industry must always be considered, there are a number of reasons why they 117 
need not always preclude effective analgesia: 118 
• Many analgesic protocols (such as local anaesthetic techniques) are inexpensive to 119 
perform. Local anaesthetic drugs are economical and volumes required are 120 
generally low. Time spent in performing these techniques is also usually low, and 121 
will decrease as the experience of the clinician grows.  122 
• Financial benefits are often an unexpected outcome of analgesic treatment. 123 
Increases in parameters such as growth rate after calf disbudding (Faulkner and 124 
Weary 2000) and milk yield after lameness cases (O'Callaghan-Lowe and others 125 
2004) have been reported after analgesic therapy was combined with standard 126 
treatments. Whilst this increased performance may not cover the total cost of 127 
analgesic treatment, in the majority of situations it will partially offset the cost. 128 
• Prices of the most commonly used non-steroidal anti-inflammatory drugs 129 
(NSAIDs) may fall in the future as more generic products become available. 130 
 131 
Clinicians too often assume that farmers are unwilling to carry costs associated with 132 
improvements to the welfare of their animals. In the case of many farm animal owners 133 
(especially “hobby” farmers or owners of small herds), the client may be more 134 
prepared to pay than the clinician realises. A recent survey of commercial UK cattle 135 
farmers (with over 1,000 respondents) has demonstrated that for the majority of 136 
owners the cost of analgesics remains a significant issue; however this was not true 137 
for all respondents. When asked to state how much they would be prepared to pay for 138 
analgesics during and following the treatment of a range of conditions and procedures, 139 
the answers varied considerably. For all 13 conditions considered, a small minority of 140 
respondents stated they would consider between £35 and £50 (the highest bracket) an 141 
acceptable cost for analgesic treatment, but a more significant number were prepared 142 
to meet a lower cost. For example, when considering surgical castration of calves, 143 
32% of respondents stated they would pay between £5 and £10 and eight percent 144 
stated £11 or more. When considering caesarean section surgery, 28% of respondents 145 
stated they would pay £11 to £20, 13% stated £21 to £35 and 6% stated £36 to £50 146 
and when considering disbudding, 21% stated they would pay £5 to £10 and 4% 147 
stated £11 or more. This work suggests that for some owners cost is not the issue 148 
practitioners may initially believe and therefore it is important to offer a variety of 149 
costed analgesic treatment protocols for painful procedures and conditions.  150 
 151 
One of the most noteworthy findings in the practitioner survey (Huxley and Whay 152 
2006), was that respondents who did not use any analgesic agents during treatment 153 
estimated significantly lower pain scores for the condition or procedure in question 154 
(Table 1). This suggests that one of the key motivators for analgesic usage is the 155 
attending clinician’s own perceptions of the patient’s suffering. Therefore, one of the 156 
barriers for the provision of appropriate analgesia in cattle is, in some cases, an 157 
unwillingness or inability to consider or identify the level of pain cattle are suffering. 158 
 159 
Misconceptions about Analgesia and Cattle  160 
A number of common misconceptions also emerged from the survey. These are 161 
summarised and discussed below: 162 
• Age of the animal: Young animals are often assumed to feel less pain than adults. 163 
A good example of this is the lack of analgesia used in castrating calves and lambs 164 
using rubber ring techniques. There is no evidence to show that young animals 165 
perceive pain to a lesser extent than adults. In the authors’ opinion, young animals 166 
should be considered in exactly the same manner as adult animals.  167 
• Pain restricts movement which may be potentially damaging to the animal’s 168 
condition: If movement is likely to be damaging to an animal’s condition 169 
appropriate analgesia should be provided and movement should be restricted by 170 
penning the animal tightly, rather than relying on the animal’s suffering. 171 
• Analgesia may mask deterioration in the condition of the animal: This view is 172 
likely to have stemmed from received wisdom in equine practice, where it has been 173 
considered that use of potent anti-endotoxic drugs such as flunixin may hamper 174 
monitoring of colic cases. Farm animals are rarely monitored on such a short-term 175 
basis, and other clinical signs can be used in these species to monitor progression 176 
of a disease. 177 
• Corticosteroids are effective analgesic agents: Although corticosteroids are 178 
potent anti-inflammatories and act on the same pathway as NSAIDs, at therapeutic 179 
dose rates they are likely to produce less profound analgesia than NSAIDs. 180 
 181 
Techniques for Alleviating Pain 182 
An important concept in terms of alleviation of pain in cattle is that of pre-emptive 183 
versus reactive analgesia. Where pain is predictable (e.g. surgical procedures), it is 184 
preferable to provide pre-emptive analgesia. By ensuring that effective analgesia is in 185 
place before the onset of pain, phenomena such as wind-up, hyperalgesia and 186 
allodynia can be reduced or prevented. Obviously this is not always possible, but 187 
provision of analgesia as soon as possible after the onset of pain will minimise these 188 
effects. It should always be remembered that pre-emptive analgesia is likely to be 189 
more effective than reactive analgesia. 190 
 191 
Multimodal analgesia is also an important concept. It is well recognised in human and 192 
companion animal medicine that the most effective analgesia is provided by using a 193 
combination of agents that act on different pathways, but this is an often-neglected 194 
strategy in relation to cattle, where it could frequently be gainfully employed (e.g. the 195 
use of an epidural containing local anaesthetic and xylazine, combined with systemic 196 
NSAID to provide analgesia for dystocia).  197 
 198 
There are several routes that can be used to provide analgesia to cattle. Systemic 199 
treatment involves parenteral administration of systemically active analgesic agents, 200 
while local techniques such as epidural anaesthesia, local nerve blocks and 201 
intravenous regional anaesthesia provide analgesia to specific areas. 202 
 203 
Systemic Analgesic Techniques 204 
The main groups of analgesic drugs available for use in animals are NSAIDs, 2-205 
agonists and opioids. Licensing is a major issue in prescribing for food producing 206 
animals (see Box Figure 1), and this places a major restriction on the agents that can 207 
be used in cattle. A variety of NSAIDs are licensed, along with the 2-agonist 208 
xylazine. 209 
• NSAIDs: This class of drugs works by inhibition of inflammatory mediators (see 210 
Box Figure 2). They provide effective analgesia for mild to moderate pain, and are 211 
administered by a variety of routes (see Table 2). They also have anti-endotoxic 212 
effects, which provide major benefits in terms of morbidity and mortality in some 213 
disease states.  Duration of activity is generally in the range 24-72 hours per dose. 214 
Some products are licensed for repeated administration (up to a maximum of five 215 
days of treatment), but have been used for longer periods with few reports of side-216 
effects (although abomasal ulceration has been reported anecdotally). 217 
•  2-agonists: These agents work by activation of 2-adrenoreceptors in the central 218 
and peripheral autonomic nervous system. These have a negative effect on 219 
sympathetic activity and release of noradrenaline, leading to sedation and 220 
analgesia. They can provide deep sedation and effective analgesia for moderate 221 
pain in cattle. As the sedative and analgesic effects of this class of drug go 222 
together, they are more useful during some types of surgery and are not used for 223 
provision of longer-term analgesia. Xylazine is the only licensed drug in this class. 224 
• Opioids: Opioids are very potent analgesics, and are an important component of 225 
multimodal analgesia protocols in other species. However, under current 226 
legislation, no opioid agents are available for use in cattle. 227 
 228 
Regional and Local Techniques 229 
The main techniques for providing local analgesia are epidural analgesia, intravenous 230 
regional anaesthesia and nerve blocks. 231 
• Epidural analgesia: This technique involves injection of analgesic agents into the 232 
epidural space, to provide desensitisation of nerves leaving the spinal cord. 233 
Although outside the scope of this article, a full description of the technique, which 234 
is quick and straightforward to perform in cattle, is provided by Holden (1998). 235 
Low-volume (4-6ml of injectate for an adult bovine) epidural anaesthesia is most 236 
commonly performed, providing anaesthesia of the genital tract, rectum and 237 
perinaeal area and abolition of tenesmus. High volume (up to 100ml per adult 238 
bovine) techniques are also described, and may be used to provide anaesthesia for 239 
the entire abdomen. High volume techniques will involve loss of motor control to 240 
the hindlimbs, so will result in the patient becoming recumbent. Local anaesthetic 241 
is the most commonly used agent, but xylazine has also been extensively used. 242 
Xylazine provides a longer duration of action compared to local anaesthetic alone, 243 
and the two agents are often used in combination (Grubb and others 2002). A 244 
number of dosage regimes are described, including a xylazine dosage of 0.05mg/kg 245 
(1.25ml of 2% xylazine per 500kg) with the remainder of the injectate made up of 246 
local anaesthetic. This use of xylazine is not licensed.  247 
• Intravenous regional anaesthesia (IVRA): This is another quick and easy 248 
technique (see Box Figure 3 for description). It provides desensitisation of the limb 249 
distal to the tourniquet, and so is very useful for painful procedures in the foot 250 
(both foot surgery and treatment of severe claw horn lesions). It should be 251 
remembered that the effects of the IVRA will quickly wear off once the tourniquet 252 
is released, and no ongoing analgesia is provided. It is therefore usually advisable 253 
to use NSAIDs in combination, to provide a longer duration of effective pain relief. 254 
This use of local anaesthetic is off-licence. 255 
• Local nerve blocks: A number of nerve block techniques are described in cattle. 256 
Again, specific description of the techniques is outside the scope of this article, but 257 
have been described previously (Edwards 2001). These techniques are summarised 258 
in Table 3. Local anaesthetics (procaine is now the only licensed product in food 259 
producing animals) are the most commonly used agents, providing 30-90 minutes 260 
of effective anaesthesia. Local anaesthetic/xylazine combinations may also be used 261 
for these techniques, and are thought to provide an extended duration of analgesia. 262 
Again, this is off-licence, and there is little research evaluating the combination. It 263 
has been suggested that 2-agonists are unlikely to have local effects and that any 264 
clinical differences seen may be due to systemic absorption. With this in mind, the 265 
possibility of sedation as a side-effect should be considered. 266 
 267 
Ring blocks are a method for blocking distal appendages (e.g. teats and distal 268 
limbs). Local anaesthetic is introduced at various points and depths around the 269 
circumference of the appendage in order to block nerve supply distal to the 270 
location of injection. These require multiple injections, and are generally less 271 
effective. In addition, as procaine with adrenaline is the only licensed product, the 272 
potential vasoconstrictive effect of infiltrating adrenaline around a small 273 
appendage (e.g. a teat) should also be considered, as necrosis may result. 274 
Infiltration of local anaesthetic around the area to be desensitised is also useful in 275 
some situations. 276 
 277 
 278 
Suggested Standard Operating Procedures for Management of 279 
Pain in Specific Situations 280 
Standing Flank Laporotomy in Adult Cattle 281 
• Systemic NSAID before the start of surgery. 282 
• Systemic xylazine could be used, but extreme care would be needed with dose to 283 
ensure the animal does not become recumbent. May be useful to provide extra 284 
short-term analgesia if a very painful procedure is anticipated. May be necessary in 285 
very fractious patients. 286 
• Paravertebral nerve blocks to provide effective anaesthesia of the flank area using 287 
procaine. 288 
• Epidural anaesthesia may be used in the case of a caesarean section, to abolish 289 
tenesmus that may hinder surgery. 290 
 291 
Castration and Disbudding of Calves 292 
• Cornual nerve block using local anaesthetic (possibly in combination with low 293 
dose perineural xylazine in some cases - although this use of xylazine is off-294 
licence, the consequences of which would have to be explained to the owner). 295 
• Local infiltration of local anaesthetic in the skin of the distal scrotum (surgical 296 
castration) and over the neck of the scrotum to provide analgesia to the spermatic 297 
cord (surgical and burdizzo castration). Injection of local anaesthetic into the testes 298 
themselves may or may not be used. 299 
• Where economically acceptable, pre-emptive use of NSAIDs is a desirable 300 
addition to the protocol. Several researchers have found welfare benefits as a result 301 
(Earley and Crowe 2002; Ting and others 2003). Clinicians too often fail to offer 302 
this option to clients, who may well be happy to the relatively small cost of 303 
extended analgesia. 304 
 305 
Foot surgery/ treatment of severe claw horn lesions e.g. severe sole ulcers 306 
• Systemic NSAID before start of treatment. 307 
• IVRA for short-term anaesthesia of the foot. 308 
 309 
Other potentially painful conditions where NSAID use should be 310 
considered 311 
 312 
• Joint ill and navel ill in calves: Septic arthritis in particular is considered to be an 313 
extremely painful condition in humans and companion animals, but analgesia is too 314 
often neglected in cattle. 315 
• Mastitis: NSAIDs should be considered for use in all cases of mastitis involving 316 
udder or systemic signs (as opposed to mastitis where signs are restricted to milk 317 
changes) (Milne and others 2003). 318 
• Lameness: In addition to foot surgery and radical treatment of severe claw horn 319 
lesions, benefits are also seen as a result of NSAID use in less severe lameness 320 
cases (O'Callaghan-Lowe and others 2004). 321 
• Dystocia: NSAID use is relatively common following dystocia. It is worth 322 
considering providing analgesia to the calf as well as the dam. 323 
• Uveitis and keratoconjunctivitis: These are both relatively common ocular 324 
conditions in cattle (“silage eye” and “New Forest eye”), and the underlying 325 
pathology (uveitis and corneal ulceration respectively) is considered to produce 326 
severe pain in humans and companion animals. As well as providing analgesia, 327 
NSAIDs may increase speed of response to treatment by decreasing inflammation 328 
in cases of uveitis. 329 
 330 
Conclusions 331 
Despite an increase in research into and awareness of pain in cattle over the last 332 
fifteen years, management of painful conditions in cattle is still too rarely considered 333 
in practice. This article provides information on the methods by which analgesia may 334 
be provided, as well as suggesting standard protocols for pain management in specific 335 
conditions. 336 
337 
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Box figure 1 – place near reference in main text (line 193) 387 
Licensing of Veterinary Medicines 388 
Licensing issues have a major effect on product choices in farm animal medicine. The 389 
Veterinary Medicines Regulations (2005) provide for administration of products 390 
outside the terms of the product’s marketing authorisation under the prescribing 391 
“cascade”. However, they state that “any pharmacologically active substances 392 
included in a medicinal product administered to a food-producing animal under the 393 
cascade must be listed in Annex I, II or III to Council Regulation (EEC) No. 394 
2377/90.”  Annex I lists substances for which a definitive maximum residue limit 395 
(MRL) has been established. These are generally found in products which have an 396 
authorisation for use in food producing animals. Annex II lists substances which, 397 
following initial evaluation by the European Medicines Agency (EMEA), were 398 
deemed to pose sufficiently little risk to public health not to necessitate the 399 
determination of a MRL. Annex III lists substances which are undergoing MRL 400 
determination at the current time and have been given provisional MRLs as there are 401 
considered to be no outstanding ongoing safety issues. 402 
 403 
In practical terms, this means that only pharmacologically active substances listed in 404 
Annexes I, II and III can be used in veterinary medicinal products for use in food 405 
production animals. The only potentially useful compounds listed in Annex II for food 406 
producing animals are ketamine and thiopentone (butorphanol, isoflurane and 407 
lidocaine are also listed but the listing is restricted to equidae only). This restricts 408 
drugs for use as analgesics to a variety of NSAIDs, procaine and xylazine (with 409 
ketamine and thiopentone the only options for general anaesthesia). Further and 410 
frequently updated information is available from 411 
http://www.emea.europa.eu/index/indexv1.htm. 412 
413 
Box figure 2 – place near reference in text (line 197) 414 
Mode of Action of NSAIDs 415 
 416 
A simplified mode of action for NSAIDs is given in the diagram above. Inhibition of 417 
cyclo-oxygenase (COX) enzymes decreases prostaglandin synthesis, thereby 418 
decreasing pain and inflammation. As well as mediating inflammation, some COX-1 419 
enzymes have alternative “housekeeping” functions and are induced in the absence of 420 
cellular damage. Their roles include gastroprotection and maintenance of renal 421 
bloodflow. Inhibition of these enzymes can bring about the side-effects of NSAIDs, 422 
notably gastric ulceration and renal disease. These are not well recognised in farm 423 
animals, although there have been anecdotal reports of abomasal ulceration in calves 424 
after treatment with NSAIDs. One possible reason for the apparent lack of side effects 425 
is the short term nature of the vast majority of NSAID use in these species. NSAIDs 426 
that preferentially inhibit COX-2 enzymes to a greater degree than COX-1 may be 427 
less likely to produce side effects. 428 
 429 
Cellular damage 
Phospholipase A2 
Arachidonic acid 
Cyclo-oxygenase 1&2 Lipoxygenase 
Prostaglandins Leukotrienes 
Pain/Inflammation 
- 
- - 
NSAIDs LOX-inhibitors 
corticosteroids 
It is clear from the diagram that production of leukotrienes by induction of the 430 
enzyme lipoxygenase (LOX) is also an important inflammatory pathway. LOX 431 
inhibitors are available in human and companion animal medicine (e.g. tepoxalin), but 432 
as yet none are licensed for farm animals. However, there is evidence that tolfenamic 433 
acid has some inhibitory activity against LOX. Some NSAIDs are also though to have 434 
a direct inhibitory action on leukotrienes. 435 
 436 
A third COX enzyme has been identified (COX-3). Inhibition of this enzyme is 437 
thought to be responsible for some of the activity of paracetamol (a NSAID-like agent 438 
which is considered to have relatively little COX-1 and -2 inhibition). While 439 
paracetamol is not clinically relevant to cattle, the activity of carprofen may also be 440 
partly due to COX-3 inhibition. Other factors, such as how effectively the agent 441 
crosses the blood-brain barrier, may also be significant in determining the 442 
effectiveness of a NSAID. 443 
444 
Box figure 3 – place near reference in text (line 235) 445 
Intravenous Regional Anaesthesia for the Bovine Hindlimb: A 446 
Standard Operating Procedure 447 
 448 
IVRA is a quick and simple technique to perform, and is underused in the treatment of 449 
lame cows. 450 
Equipment required: 451 
• Appropriate handling facilities (i.e. foot trimming crush) 452 
• Clippers/scissors 453 
• Chlorhexidine surgical scrub 454 
• Surgical spirit 455 
• Tourniquet (a bicycle tyre inner tube is a good choice) 456 
• 20-30ml local anaesthetic in syringe (procaine is now the only legal option), 457 
depending on the size of the animal 458 
• 18 gauge, 1.5 inch needle 459 
Procedure: 460 
• The animal is restrained in the crush, with the affected limb raised. The procedure 461 
is easier to perform if the limb is not tied to the upright of the crush (as this will get 462 
in the way of the injection site).  463 
• The dorsolateral aspect of the metatarsus is clipped and surgically prepared. 464 
• A tourniquet is applied to the limb, either below or above the hock. If the 465 
tourniquet is above the hock, rolls of bandage or similar may be required to fill the 466 
spaces either side of the gastrocnemius tendon. For this reason, the authors prefer 467 
to apply it below the hock. The tourniquet must be applied sufficiently tightly and 468 
secured. 469 
• The lateral saphenous vein is palpated running directly up the dorsolateral aspect of 470 
the metatarsus. The needle is then placed in the vein (directed distally), with the 471 
entire length of the needle in the lumen of the vessel. A good needle placement 472 
increases stability of vascular access while the local anaesthetic is injected. 473 
• Blood is allowed to drain through the needle until the pressure drops so that blood 474 
is dripping rather than running out of the hub. 475 
• The syringe is connected and the local anaesthetic slowly injected. 476 
• After five to ten minutes, desensitisation of the foot can be checked by pricking the 477 
skin of the interdigital space with a sterile needle. 478 
• When the procedure is finished, the tourniquet should be removed gradually (to 479 
prevent the theoretical possibility of a bolus of local anaesthetic entering the 480 
circulation). This is more important if the procedure has been very short. 481 
 482 
The procedure is easily adapted to use in a forelimb (although restraint can be more 483 
difficult in this situation, and it is worth considering casting the animal). 484 
485 
Box figure (no reference) – place anywhere in second half of text (preferably around 486 
“Techniques for alleviating pain” section, lines 168-264) 487 
General Anaesthesia in Farm Animals 488 
In many respects, general anaesthesia can be thought of as the “gold standard” in 489 
terms of pain management. However, it is important to remember that induction of 490 
and recovery from general anaesthesia are stressful processes and that general 491 
anaesthesia only provides pain relief for the duration of the anaesthetic. Some agents 492 
have very poor analgesic properties, and multimodal pain relief should be employed. 493 
 494 
Detailed descriptions of anaesthetic techniques are outside the scope of this article, 495 
but general anaesthesia (either in the field or in a hospital setting) is a useful 496 
procedure, particularly in young animals (the weight of the gastrointestinal tract 497 
makes it more dangerous in adults). Licensing restrictions affect which products may 498 
be used, but anaesthesia may be induced using a xylazine and ketamine combination, 499 
and maintained with incremental doses of ketamine. A side-benefit of the use of 500 
ketamine is that, as an NMDA antagonist, it is thought to interrupt central pain 501 
amplification processes (wind-up). Endotracheal intubation (with or without oxygen 502 
supplementation) is recommended in all cases, even though volatile agents cannot be 503 
used for maintenance. Obviously, this is only suitable for shorter procedures. 504 
Isoflurane could be used for maintenance to make longer procedures practicable, but 505 
under current licensing rules this is not allowed. 506 
507 
Box figure (no reference) – place anywhere in first half of text (preferably near 508 
“Barriers to treatment” and “Misconceptions about analgesia and cattle” sections, 509 
lines 97-167) 510 
Legal Aspects of Analgesia 511 
The major legislation relevant specifically to this area is summarised below: 512 
• Protection of Animals (Anaesthetics) Act 1954 (as amended) states that 513 
anaesthetic must be used for “any operation, with or without the use of 514 
instruments, which involves interference with the sensitive tissues or the bone 515 
structure of an animal” with the exception of injection or extraction by means of a 516 
hollow needle. Some specific exclusions apply (e.g. life-saving or emergency first 517 
aid treatment or minor procedures customarily performed without anaesthetic). 518 
With regard to routine husbandry procedures in calves, anaesthetic must be used 519 
when: 520 
o Castrating calves over two months of age 521 
o Disbudding or dehorning cattle of any age (with the exception of 522 
chemical cautery, which is only permitted during the first week of life) 523 
o Removing supernumerary teats from calves of over three months of 524 
age 525 
• More generally, the Agriculture (Miscellaneous Provisions) Act 1968 states that 526 
it is an offence to cause unnecessary pain or unnecessary distress to any livestock 527 
on agricultural land. 528 
• Similarly, the Welfare of Farmed Animals (England) Regulations 2000 state 529 
that owners and keepers of animals shall take all reasonable steps: 530 
o To ensure the welfare of the animals under their care; and 531 
o To ensure that the animals are not caused any unnecessary pain, 532 
suffering or injury.  533 
• The most relevant issues raised by the new Animal Welfare Act 2006 are the 534 
requirement for the person responsible for an individual animal to comply with 535 
“good practice” in order satisfy the animals need to be “protected from pain”, and 536 
the concept that duty of care passes from the owner/keeper to the veterinary 537 
surgeon during treatment of the animal. 538 
539 
Box figure (no reference) – place anywhere in second half of text, preferably near to 540 
“Techniques for alleviating pain” section (lines 168-264) 541 
Provision of Long Term Analgesia to Farm Animals 542 
Providing long-term pain management to farm animals with chronically painful 543 
conditions is currently difficult. This is largely due to licensing restrictions and cost. 544 
In the past, oral phenylbutazone has been used for this purpose, but use of 545 
phenylbutazone in food producing species is now illegal. 546 
 547 
The alternative approach is the use of repeated doses of injectable NSAID. This is off-548 
licence beyond five days, although it could be justified under the cascade system (as 549 
authorised NSAIDs all have established MRL values, the standard withdrawal periods 550 
of seven days milk withdrawal and 28 days meat withdrawal would apply). The safety 551 
of long-term NSAID treatment in farm animals has not been extensively researched, 552 
although there were anecdotal reports of long term phenylbutazone use being well 553 
tolerated. The major barrier to long-term use of parenteral NSAID is cost: ketoprofen 554 
given daily would cost approximately £1.20 - £1.70/100kg/day, while meloxicam 555 
given every three days would cost £0.57/100kg/day (at list price). This level of 556 
expenditure may only be justified in a limited number of cases, so use of NSAIDs is 557 
usually restricted to coverage of episodes of acute pain. Euthanasia should always be 558 
seriously considered in cases where an animal is likely to experience long-term pain. 559 
560 
Table 1 – place near reference in text (line 141) 561 
 562 
 563 
Caption: A recent survey of UK cattle practitioners with over 500 respondents asked 564 
clinicians to judge the severity of pain associated with a range of procedure and 565 
conditions on a ten point scale (1 = No pain at all; 10 = The worst pain imaginable). 566 
The results are outlined in the table below. The median pain score is the score 567 
assigned by the middle clinician if all the scores are arranged in ascending order and 568 
the modal pain score was the most frequently given answer.  569 
 570 
 571 
 
 
Median 
Pain 
Score 
Range 
- Min 
Range 
- Max 
Modal 
Pain 
Score 
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Treatment of a sole ulcer 6 1 10 7 
Claw amputation 10 2 10 10 
Caesarean section 9 1 10 10 
Dystocia1 7 2 10 8 
De-horning2 8 2 10 10 
Debriding a digital dermatitis 
lesion 6 1 10 5 
LDA surgery 9 2 10 10 
A
d
u
lt
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at
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s 
Uveitis 6 1 10 7 
Fracture of tuber coxae 7 2 10 8 
LDA 3 1 10 3 
Digital dermatitis 6 2 10 5 
Acute Metritis 4 1 10 3 
Swollen hock 5 1 10 5 
Hock with hair loss 3 1 10 2 
Acute toxic Escherichia coli 
mastitis 7 1 10 7 
Mastitis (clots in milk only) 3 1 10 2 
Neck calluses 2 1 7 2 
White line disease with Sub-
sole abscess 7 1 10 7 
C
al
f 
P
ro
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s 
Calf castration (Surgical) 6 2 10 5 
Calf castration (Rubber ring) 6 1 10 5 
Calf castration (Burdizzo) 7 2 10 8 
Umbilical hernia surgery 8 2 10 10 
Disbudding 7 2 10 8 
C
al
f 
C
o
n
d
it
io
n
s 
Distal limb fracture 8 2 10 8 
Following dystocia1 4 1 10 3 
Umbilical abscess 5 1 10 4 
Joint ill 7 1 10 8 
Pneumonia 6 1 10 5 
Footnote: Respondents were asked to estimate the severity of pain assuming NO analgesic drugs were administered 572 
1Fetal-maternal disproportion requiring traction alone 573 
2Horns >8cm/3” 574 
Reproduced from Huxley and Whay (2006).  575 
 576 
 577 
Place near to reference in text (line 198)  
Table 2: Costs of commonly used drugs and techniques. 
 Products Licensed 
route(s) 
Milk/meat 
withdrawal 
Dose rate Cost 
/ml 
Cost 
/100kg 
Licensed indications 
Systemic       
NSAIDs       
Carprofen Rimadyl™ (Pfizer) i/v, s/c n-l/21d 1ml/35kg 121p £3.442 Respiratory disease 
Flunixin Binixin™ (Bayer) 
Cronyxin™ (Bimeda) 
Finadyne™ (Schering Plough) 
Meflosyl 5% (Fort Dodge) 
i/v 12-36h/ 
5-8d 
2ml/45kg 12-
42p 
51p – 
£1.86 
Respiratory disease, mastitis 
Ketoprofen Comforion™ (Janssen) 
Ketofen™ (Merial) 
i/v, i/m 0/1-4d 1ml/33kg 39-
61p 
£1.18- 
£1.85 
Parturient paresis, 
respiratory disease, mastitis, 
udder oedema1 
Meloxicam Metacam™ (Boehringer 
Ingelheim) 
i/v, s/c 5d/15d 2.5ml/100kg 75p £1.882 Respiratory disease, 
mastitis, diarrhoea in 
youngstock 
Tolfenamic acid Tolfine™ (Vetoquinol) i/v, s/c 
(s/c limited) 
24h/3-7d 1ml/10kg or 
1ml/20kg3 
29p £1.44 - 
£2.87 
Mastitis, respiratory disease 
2-agonists       
Xylazine4 Chanazine™ 2% (Chanelle) 
Rompun™ 2% (Bayer) 
Sedaxylan™ (CEVA) 
Virbaxyl™ 2% (Virbac) 
Xylacare™ 2% (Animalcare) 
Xylapan™ (Vetoquinol) 
i/v 
(Sedaxylan 
only), i/m 
0d-24h, 
some n-l / 
1d – 14d 
0.15 – 1.5ml 
/100kg 
91p - 
£1.39 
18p - 
£2.09 
Sedation, muscle relaxation 
and analgesia. See data 
sheets for specific 
indications. 
Local techniques       
Procaine Willcain™ (Arnolds)  0/0 Depends on 3.5p/   
                                                 
1 Indications vary between the two licensed products. 
2 Meloxicam and carprofen may have longer durations of action than the other NSAIDs. 
3 Dose rate for tolfenamic acid varies with indication 
4 Xylazine should be used with caution in potentially pregnant animals – see data sheet for further information. 
technique: ml 
    epidural5  18p  
    cornual  35p  
    paravertebral  £2.80  
    IVRA5  88p  
 
i/v = intravenous, i/m = intramuscular, s/c = subcutaneous 
n-l = not licensed for use in lactating cattle 
 
This is not a comprehensive list – it is restricted to those products listed in the NOAH data sheets compendium. Other NSAIDs for animal use 
are available. Drug costs are given at list price. Costs and dose rates are intended as guides only – the product datasheet should always be 
consulted before administering a medicine. The authors accept no liability for costs arising due to errors in this material. 
                                                 
5 Use of procaine by this route is off-licence. 
Place near to reference in text (line 245). 
Table 3: Nerve blocks commonly used in cattle. 
Nerve block Area of analgesia Notes 
Paravertebral Flank 
Quick and simple way to provide 
anaesthesia for flank surgery 
Cornual 
Horn and surrounding skin 
in calves 
Less effective in adults 
Retrobulbar Eye and adnexa 
May result in damage to adnexal 
structures, usually reserved for 
enucleation 
Peterson 
Eye and adnexa except 
eyelids 
Less destructive than retrobulbar, 
need to anaesthetise eyelids 
separately for enucleation. 
Auriculopalpebral 
Eyelids (motor function 
only) 
Provides paralysis but not 
desensitisation of eyelids 
Common peroneal 
and tibial 
Hindlimb distal to tarsus 
A good alternative to IVRA, 
although technically more difficult. 
 
 
